Here are the latest quarterly results of ELDER PHARMA. For more details, see the ELDER PHARMA financial fact sheet and ELDER PHARMA share price. For a sector overview, read our pharmaceuticals sector report.
No. of Mths Qtr. Ending |
3
Jun-13* |
3
Sep-13* |
3
Dec-13* |
3
Mar-14* |
3
Jun-14* |
3
Sep-14* |
3
Dec-14* |
3
Mar-15* |
8-Qtr Chart Click to enlarge |
|
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | Rs m | 1,851 | 2,728 | 3,871 | 2,289 | 1,202 | 2,031 | 1,579 | 1,521 | |
Other income | Rs m | 23 | 64 | 44 | 127 | 21 | 93 | 9 | 11 | |
Turnover | Rs m | 1,873 | 2,792 | 3,914 | 2,416 | 1,223 | 2,125 | 1,589 | 1,531 | |
Expenses | Rs m | 1,276 | 2,288 | 3,536 | 2,374 | 2,684 | 2,287 | 1,885 | 1,637 | |
Gross profit | Rs m | 545 | 440 | 330 | -56 | 2,207 | -215 | -305 | -113 | |
Depreciation | Rs m | 82 | 92 | 111 | 95 | 63 | 113 | 89 | 104 | |
Interest | Rs m | 478 | 368 | 493 | 695 | 1,200 | 232 | 450 | 225 | |
Profit before tax | Rs m | 8 | 44 | -230 | -719 | 965 | -467 | -836 | -431 | |
Tax | Rs m | -0 | 13 | 3 | 17 | -0 | 1 | 0 | 29 | |
Profit after tax | Rs m | 8 | 31 | -233 | -736 | 966 | -469 | -836 | -460 | |
Gross profit margin | % | 29.5 | 16.1 | 8.5 | -2.5 | 183.6 | -10.6 | -19.3 | -7.4 | |
Effective tax rate | % | -3.2 | 28.6 | -1.4 | -2.4 | -0.1 | -0.3 | -0.0 | -6.7 | |
Net profit margin | % | 0.5 | 1.2 | -6.0 | -32.2 | 80.3 | -23.1 | -52.9 | -30.3 | |
Diluted EPS | Rs | 0.4 | 1.5 | -11.4 | -35.9 | 47.0 | -22.8 | -40.7 | -22.4 | |
Diluted EPS (TTM) | Rs | NA | NA | NA | -45.3 | 1.3 | -23.0 | -52.4 | -38.9 | |
Subscriber Feature |
Indian benchmark indices remained positive as the session progressed and ended the day on firm footing.